The Cardio-Metabolic Clinic
Conditions: Diabetes Mellitus, Type 2; Cardiovascular Diseases Interventions: Other: Cardio-Metabolic Clinic Sponsors: Odense University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
NYSCF Scientific Discovery Biobank
Conditions: ALS; Amyotrophic Lateral Sclerosis; Alzheimer Disease; Alzheimer Disease, Early Onset; Alzheimer Disease, Late Onset; Batten Disease; Corticobasal Degeneration; Dementia; Frontotemporal Dementia; Huntington Disease; Lewy Body Disease; Multiple Sclerosis; Multiple System Atrophy; Parkinson Disease; Parkinson ' s Disease and Parkinsonism; Progressive Supranuclear Palsy; INAD; Diabetes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1; Macular Degeneration; Ovarian Cancer; Cervical Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer; PTSD; Post Traumatic Stress Disorder Interventions: Othe...
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Efficacy of NOSHINtrial in Diabetic Patients
Conditions: Type 2 Diabetes Mellitus With Multiple Complications Interventions: Drug: anti-diabetic herbal drug Sponsors: Kerman Medical University; Afzalipour Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Paroxetine; Drug: Placebo Sponsors: aya ramadan ashmawy sarhan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects With T2DM
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: GZR4 Injection; Drug: Insulin Degludec Sponsors: Gan and Lee Pharmaceuticals, USA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Cognitive Behavioral Therapy for Insomnia in Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes; Insomnia Interventions: Behavioral: cognitive behavioral therapy for insomnia; Behavioral: Health education Sponsors: Mahidol University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Na ïve or Insulin Treated Subjects With T2DM
Conditions: Type 2 Diabetes Interventions: Drug: GZR101; Drug: insulin degledec/insulin aspart Sponsors: Gan and Lee Pharmaceuticals, USA Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Azithromycin Versus Doxycycline on Restistin Level in Periodontitis Patients With Type 2 Diabetes
Conditions: Periodontal Diseases; Type 2 Diabetes Interventions: Drug: Group I; Drug: Group II; Drug: Group III Sponsors: King Abdulaziz University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 10, 2024 Category: Research Source Type: clinical trials
Effects of a Health Intervention on Fear of Hypoglycemia : a Pilot Study
Conditions: Type 2 Diabetes Mellitus; Fear of Hypoglycemia; Health Education; Impaired Awareness of Hypoglycemia; Self-Management Interventions: Behavioral: Based on BCW Theory of Health Education; Behavioral: General diabetes health education Sponsors: Yangzhou University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2024 Category: Research Source Type: clinical trials
Semaglutide Associated with Lower Risk of Suicidal Ideations Compared to Other Treatments Prescribed for Obesity or Type 2 Diabetes
NIH-funded analysis finds patients treated with semaglutide had 49% to 73% lower risk of suicidal ideation than those given other medications.
January 5, 2024 -- Semaglutide, a highly popular medication approved by the U.S. Food and Drug... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 5, 2024 Category: Pharmaceuticals Source Type: clinical trials
Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery
Conditions: Bariatric Surgery; Type 2 Diabetes Interventions: Drug: Capsulized fecal microbiota transfer containing the healthy feces + stool dilution solution; Drug: Capsulized placebo transfer containing dilution solution Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin
Conditions: Type 2 Diabetes Interventions: Drug: Orforglipron; Drug: Dapagliflozin Sponsors: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Web-Based Education for Individuals With Type-2 Diabetes
Conditions: Diabetes Mellitus, Type 2 Interventions: Other: Web Based Education Sponsors: Near East University, Turkey Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
A Prospective, Open, Self-controlled Study of the Effects of Chiglitazar Sodium on Glucose and Lipid Metabolism in Patients With Type 2 Diabetes Mellitus (T2DM)
Conditions: Diabetes Interventions: Drug: Chiglitazar sodium Sponsors: Yufan Wang Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
Conditions: Type 2 Diabetes; Chronic Kidney Diseases Interventions: Diagnostic Test: Oral sodium suppression test; Diagnostic Test: Saline suppression test; Diagnostic Test: Captopril suppression test; Diagnostic Test: Dexamethasone suppression test; Diagnostic Test: Cosyntropin stimulation test Sponsors: Brigham and Women ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
